Swiss National Bank Novavax Inc Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Novavax Inc stock. As of the latest transaction made, Swiss National Bank holds 247,800 shares of NVAX stock, worth $1.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

247,800

Previous 247,800 -0.0%

Holding current value

$1.99 Million

Previous $3.14 Million 0.26%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$3.89 - $20.97 $143,152 - $771,696	36,800 Added 17.44%	247,800 $3.14 Million
Q1 2024 May 07, 2024	BUY	$3.76 - $6.02 $115,808 - $185,416	30,800 Added 17.09%	211,000 $1.01 Million
Q3 2023 Nov 08, 2023	SELL	$6.81 - $9.74 $50,394 - $72,076	-7,400 Reduced 3.94%	180,200 $1.3 Million
Q2 2023 Aug 09, 2023	BUY	$6.67 - $9.52 $120,727 - $172,312	18,100 Added 10.68%	187,600 $1.39 Million
Q1 2023 May 10, 2023	SELL	$5.76 - $12.48 $111,744 - $242,112	-19,400 Reduced 10.27%	169,500 $1.17 Million
Q4 2022 Feb 08, 2023	BUY	$8.86 - $25.04 $31,895 - $90,144	3,600 Added 1.94%	188,900 $1.94 Million
Q3 2022 Nov 09, 2022	BUY	$18.2 - $76.12 $100,100 - $418,660	5,500 Added 3.06%	185,300 $3.37 Million
Q2 2022 Aug 09, 2022	SELL	$36.28 - $75.29 $4.76 Million - $9.89 Million	-131,300 Reduced 42.21%	179,800 $9.25 Million
Q1 2022 May 09, 2022	BUY	$69.73 - $142.9 $2.94 Million - $6.02 Million	42,100 Added 15.65%	311,100 $22.9 Million
Q4 2021 Feb 08, 2022	SELL	$134.56 - $217.97 $1.28 Million - $2.07 Million	-9,500 Reduced 3.41%	269,000 $38.5 Million
Q3 2021 Nov 08, 2021	SELL	$177.8 - $270.58 $1.35 Million - $2.06 Million	-7,600 Reduced 2.66%	278,500 $57.7 Million
Q2 2021 Aug 06, 2021	BUY	$121.0 - $257.67 $17 Million - $36.3 Million	140,700 Added 96.77%	286,100 $60.7 Million
Q1 2021 May 07, 2021	BUY	$112.98 - $319.93 $779,562 - $2.21 Million	6,900 Added 4.98%	145,400 $26.4 Million
Q4 2020 Feb 05, 2021	BUY	$78.74 - $139.5 $559,054 - $990,450	7,100 Added 5.4%	138,500 $15.4 Million
Q3 2020 Nov 09, 2020	BUY	$79.44 - $178.51 $1.3 Million - $2.93 Million	16,400 Added 14.26%	131,400 $14.2 Million
Q2 2020 Aug 05, 2020	BUY	$13.86 - $83.61 $1.59 Million - $9.62 Million	115,000 New	115,000 $9.59 Million
Q4 2019 Feb 06, 2020	SELL	$3.69 - $5.22 $161,208 - $228,051	-43,688 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$4.93 - $12.2 $215,381 - $532,993	43,688 New	43,688 $256,000

Others Institutions Holding NVAX

# of Institutions

292

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $629M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Novavax Inc Transaction History